BridgeMD
New treatment option for Supraspinatus Tear
Official title Novel Treatment for Rotator Cuff Tears
ClinicalTrials.gov ID: NCT05590494
What this study is testing
- What it's testing
- The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (\<50%) of the supraspinatus tendon of the rotator cuff.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 75
You may be able to join if
- \- Evidence of partial tear (\< 50%) of the supraspinatus tendon on MRI.
You likely can't join if
- A tear of the supraspinatus tendon greater \> 50% and any areas of full thickness tearing, concomitant tears \> 25% of other rotator cuff tendons...
- Evidence of systemic illness/infection requiring oral or IV antibiotics during the recruitment period.
- Evidence of overlying skin infection or lesion at the proposed device insertion point on the shoulder.
- Previous corticosteroid injection within three months.
- Those individuals less than 25 and greater than 75 years of age will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Onalaska, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Onalaska, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.